Kim H, Park H
Toxicol Res. 2025; 41(2):105-121.
PMID: 40013078
PMC: 11850699.
DOI: 10.1007/s43188-024-00275-8.
Kochs S, Schiewe S, Foerster M, Hillmann K, Blankenstein C, Meinke M
Arch Toxicol. 2025; .
PMID: 39888425
DOI: 10.1007/s00204-025-03959-8.
Stock V, Hofer R, Lochmann F, Spanke V, Liedl K, Troppmair J
Sci Rep. 2025; 15(1):2462.
PMID: 39828876
PMC: 11743777.
DOI: 10.1038/s41598-025-86450-9.
Bauer E, Ricci C, Cecchetti D, Ciufolini G, Cicero D, Rossi M
Arch Toxicol. 2025; .
PMID: 39812830
DOI: 10.1007/s00204-024-03953-6.
Eroglu C, Yuksek M, Elasan S, Mizrak Y, Karaca B
Braz Oral Res. 2024; 38:e108.
PMID: 39536200
PMC: 11552457.
DOI: 10.1590/1807-3107bor-2024.vol38.0108.
Advances in Modeling Approaches for Oral Drug Delivery: Artificial Intelligence, Physiologically-Based Pharmacokinetics, and First-Principles Models.
Arav Y
Pharmaceutics. 2024; 16(8).
PMID: 39204323
PMC: 11359797.
DOI: 10.3390/pharmaceutics16080978.
Differences in Metabolite Profiles of Dihydroberberine and Micellar Berberine in Caco-2 Cells and Humans-A Pilot Study.
Chang C, Roh Y, Du M, Kuo Y, Zhang Y, Hardy M
Int J Mol Sci. 2024; 25(11).
PMID: 38891813
PMC: 11171481.
DOI: 10.3390/ijms25115625.
Glucocorticoid-Induced Ocular Hypertension and Glaucoma.
Harvey D, Sugali C, Mao W
Clin Ophthalmol. 2024; 18:481-505.
PMID: 38379915
PMC: 10878139.
DOI: 10.2147/OPTH.S442749.
PBPK Modeling Approach to Predict the Behavior of Drugs Cleared by Metabolism in Pregnant Subjects and Fetuses.
Le Merdy M, Szeto K, Perrier J, Bolger M, Lukacova V
Pharmaceutics. 2024; 16(1).
PMID: 38258106
PMC: 10820132.
DOI: 10.3390/pharmaceutics16010096.
Liver-on-a-chip: Considerations, advances, and beyond.
Yang Z, Liu X, Cribbin E, Kim A, Li J, Yong K
Biomicrofluidics. 2022; 16(6):061502.
PMID: 36389273
PMC: 9646254.
DOI: 10.1063/5.0106855.
Pharmacophore-Model-Based Virtual-Screening Approaches Identified Novel Natural Molecular Candidates for Treating Human Neuroblastoma.
Dain Md Opo F, Alkarim S, Alrefaei G, Molla M, Alsubhi N, Alzahrani F
Curr Issues Mol Biol. 2022; 44(10):4838-4858.
PMID: 36286044
PMC: 9600652.
DOI: 10.3390/cimb44100329.
Identification of novel natural drug candidates against BRAF mutated carcinoma; An integrative in-silico structure-based pharmacophore modeling and virtual screening process.
Dain Md Opo F, Alsaiari A, Molla M, Ahmed Sumon M, Yaghmour K, Ahammad F
Front Chem. 2022; 10:986376.
PMID: 36267655
PMC: 9577413.
DOI: 10.3389/fchem.2022.986376.
Treprostinil Supplementation Ameliorates Hepatic Ischemia Reperfusion Injury and Regulates Expression of Hepatic Drug Transporters: An Isolated Perfused Rat Liver (IPRL) Study.
Almazroo O, Shaik I, Hughes C, Humar A, Venkataramanan R
Pharm Res. 2022; 39(11):2979-2990.
PMID: 36071353
PMC: 9633539.
DOI: 10.1007/s11095-022-03384-x.
Robenacoxib pharmacokinetics in sheep following oral, subcutaneous, and intravenous administration.
Fadel C, Lebkowska-Wieruszewska B, Sartini I, Lisowski A, Poapolathep A, Giorgi M
J Vet Pharmacol Ther. 2022; 45(6):550-557.
PMID: 35899473
PMC: 9796919.
DOI: 10.1111/jvp.13089.
Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs.
Lofts A, Abu-Hijleh F, Rigg N, Mishra R, Hoare T
CNS Drugs. 2022; 36(7):739-770.
PMID: 35759210
PMC: 9243954.
DOI: 10.1007/s40263-022-00930-4.
Drug Transporters ABCB1 (P-gp) and OATP, but not Drug-Metabolizing Enzyme CYP3A4, Affect the Pharmacokinetics of the Psychoactive Alkaloid Ibogaine and its Metabolites.
F Martins M, Heydari P, Li W, Martinez-Chavez A, Venekamp N, Lebre M
Front Pharmacol. 2022; 13:855000.
PMID: 35308219
PMC: 8931498.
DOI: 10.3389/fphar.2022.855000.
In Vitro Metabolism of Donepezil in Liver Microsomes Using Non-Targeted Metabolomics.
Kim S, Seo H, Jeong Y, Lee G, Ji S, Park S
Pharmaceutics. 2021; 13(7).
PMID: 34201744
PMC: 8309179.
DOI: 10.3390/pharmaceutics13070936.
Achievements in Thermosensitive Gelling Systems for Rectal Administration.
Bialik M, Kuras M, Sobczak M, Oledzka E
Int J Mol Sci. 2021; 22(11).
PMID: 34071110
PMC: 8197127.
DOI: 10.3390/ijms22115500.
Clinical pharmacokinetic study of latrepirdine via in silico sublingual administration.
Santos J, Lobato L, Vale N
In Silico Pharmacol. 2021; 9(1):29.
PMID: 33898159
PMC: 8021625.
DOI: 10.1007/s40203-021-00083-0.
Metabolism of Long-Acting Rilpivirine After Intramuscular Injection: HIV Prevention Trials Network Study 076 (HPTN 076).
Seneviratne H, Tillotson J, Lade J, Bekker L, Li S, Pathak S
AIDS Res Hum Retroviruses. 2020; 37(3):173-183.
PMID: 33191765
PMC: 7994431.
DOI: 10.1089/AID.2020.0155.